Lantheus completes acquisition of radiopharma firm Evergreen Theragnostics for up to $1B

Founded in 2019 and headquartered in Springfield, New Jersey, Evergreen develops and manufactures imaging agents for diagnosing and treating cancer. 

Read the full article on radiologybusiness.com